Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Cosmetics

  • Print
  • Share
  • E-mail
-

BSE and Cosmetics: FDA Risk Assessment and Management Perspectives - Slide 26. BSE/ v-CJD: OCAC Role In Process of BSE Risk Analysis- II

December 7, 2006

First  |  ← Previous  |  Slide 26 of 45  |  Next →  |  Last  |  Index

Slide 26. BSE/ v-CJD: OCAC Role In Process of BSE Risk Analysis- II - See text below

BSE/ v-CJD: OCAC Role In Process of BSE Risk Analysis- II

  • Import Alert # 17-04 and Cosmetic Compliance Program (CPG 7829.001/ 7829.002) in Cosmetics "BSE-Firewall"
    • Incorporate USDA/APHIS restrictions at 9 CFR 94.18 and 9 CFR 95.4 (1998 et. seq.)
    • Bovine Ingredients Usage Establishment Inspection (EI) Questionnaire
  • 2001-2004: OCAC Representation on FDA-CFSAN Regulatory BSE Initiatives
    • CFSAN BSE Coordinating Committee
    • Regulation and Guidance Development Teams
      • BSE Emergency Response Plan (ERP)
      • BSE "Prohibited Cattle Materials" Proposal, Interim Final Rule (IFR), and Recordkeeping Proposal
-
-